These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18040647)

  • 1. Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396).
    Patek CE; Brownstein DG; Fleming S; Wroe C; Rose L; Webb A; Berry RL; Devenney PS; Walker M; Maddocks OD; Lawrence NJ; Harrison DJ; Wood KM; Miles CG; Hooper ML
    Transgenic Res; 2008 Jun; 17(3):459-75. PubMed ID: 18040647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
    Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.
    Patek CE; Little MH; Fleming S; Miles C; Charlieu JP; Clarke AR; Miyagawa K; Christie S; Doig J; Harrison DJ; Porteous DJ; Brookes AJ; Hooper ML; Hastie ND
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2931-6. PubMed ID: 10077614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.
    da Silva TE; Nishi MY; Costa EM; Martin RM; Carvalho FM; Mendonca BB; Domenice S
    Pediatr Nephrol; 2011 Aug; 26(8):1311-5. PubMed ID: 21559934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal Segmental Membranoproliferative Glomerulonephritis: A Histological Variant of Denys-Drash Syndrome.
    Karmila AB; Yap YC; Appadurai M; Oh L; Fazarina M; Abd Ghani F; Ariffin H
    Fetal Pediatr Pathol; 2021 Apr; 40(2):113-120. PubMed ID: 31707902
    [No Abstract]   [Full Text] [Related]  

  • 7. The Wt1+/R394W mouse displays glomerulosclerosis and early-onset renal failure characteristic of human Denys-Drash syndrome.
    Gao F; Maiti S; Sun G; Ordonez NG; Udtha M; Deng JM; Behringer RR; Huff V
    Mol Cell Biol; 2004 Nov; 24(22):9899-910. PubMed ID: 15509792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome.
    Hakan N; Aydin M; Erdogan O; Cavusoglu YH; Aycan Z; Ozaltin F; Zenciroglu A; Apaydin S; Gunes R; Sahin G; Cinar G; Okumus N
    Genet Couns; 2012; 23(2):255-61. PubMed ID: 22876585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pictures and novel mutations of WT1-associated Denys-Drash syndrome in two Chinese children.
    Yue Z; Pei Y; Sun L; Huang W; Huang H; Hu B; Yang J; Jiang X; Mo Y; Chen S; Lai KN; Wang Y
    Ren Fail; 2011; 33(9):910-4. PubMed ID: 21851196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WT1 Haploinsufficiency Supports Milder Renal Manifestation in Two Patients with Denys-Drash Syndrome.
    Guaragna MS; Ribeiro de Andrade JG; de Freitas Carli B; Belangero VM; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
    Sex Dev; 2017; 11(1):34-39. PubMed ID: 28081536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A familial WT1 mutation associated with incomplete Denys-Drash syndrome.
    Zhu C; Zhao F; Zhang W; Wu H; Chen Y; Ding G; Zhang A; Huang S
    Eur J Pediatr; 2013 Oct; 172(10):1357-62. PubMed ID: 23715653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development.
    Natoli TA; Liu J; Eremina V; Hodgens K; Li C; Hamano Y; Mundel P; Kalluri R; Miner JH; Quaggin SE; Kreidberg JA
    J Am Soc Nephrol; 2002 Aug; 13(8):2058-67. PubMed ID: 12138137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadal effects of a mouse Denys-Drash syndrome mutation.
    Patek CE; Saunders PT; Miles CG; Berry RL; Hastie ND; Sharpe RM; Hooper ML
    Transgenic Res; 2005 Oct; 14(5):691-702. PubMed ID: 16245160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
    Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
    Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report.
    Alge JL; Wenderfer SE; Hicks J; Bekheirnia MR; Schady DA; Kain JS; Braun MC
    BMC Nephrol; 2017 Jul; 18(1):243. PubMed ID: 28720077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
    Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
    Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral Wilms' tumor in a child with Denys-Drash syndrome: novel frameshift variant disrupts the WT1 nuclear location signaling region.
    Guaragna MS; Ledesma FL; Manzano VZ; Maciel-Guerra AT; Guerra-Júnior G; Silva MM; Luiz de Brito P; Palandi de Mello M
    J Pediatr Endocrinol Metab; 2022 Jun; 35(6):837-843. PubMed ID: 35304980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Denys-Drash syndrome. Experience gathered in Erlangen illustrated by two case reports].
    Zugor V; Zenker M; Dötsch J; Schrott KM; Schott GE
    Urologe A; 2005 Oct; 44(10):1197-200. PubMed ID: 16003530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome.
    Swiatecka-Urban A; Mokrzycki MH; Kaskel F; Da Silva F; Denamur E
    Pediatr Nephrol; 2001 Aug; 16(8):627-30. PubMed ID: 11519891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.
    Guaragna MS; Soardi FC; Assumpção JG; Zambaldi Lde J; Cardinalli IA; Yunes JA; de Mello MP; Brandalise SR; Aguiar Sdos S
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):486-8. PubMed ID: 20562648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.